Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis
Clinical trial NCT00616538 · COMPLETED
Trial details
- NCT number
- NCT00616538
- Sponsor
- Ceragenix Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2007-04-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.